William Pierce

699 total citations
17 papers, 551 citations indexed

About

William Pierce is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, William Pierce has authored 17 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Immunology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in William Pierce's work include Cancer Immunotherapy and Biomarkers (9 papers), Renal cell carcinoma treatment (5 papers) and Immunotherapy and Immune Responses (5 papers). William Pierce is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Renal cell carcinoma treatment (5 papers) and Immunotherapy and Immune Responses (5 papers). William Pierce collaborates with scholars based in United States, Austria and Israel. William Pierce's co-authors include Arie S. Belldegrun, Robert A. Figlin, W. David Henner, B A Lowe, Tomasz M. Beer, Jean B. deKernion, Nancy P. Moldawer, Faye A. Eggerding, C L Tso and Barbara J. Gitlitz and has published in prestigious journals such as Journal of Biological Chemistry, Cancer and The Journal of Urology.

In The Last Decade

William Pierce

16 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William Pierce United States 12 301 295 157 149 104 17 551
J. Luz Tovar García Colombia 7 275 0.9× 140 0.5× 145 0.9× 276 1.9× 73 0.7× 8 591
M.R. Sertoli Italy 15 432 1.4× 75 0.3× 120 0.8× 73 0.5× 92 0.9× 34 630
Carla M. van Herpen Netherlands 14 325 1.1× 146 0.5× 195 1.2× 113 0.8× 98 0.9× 27 608
Edmonson Jh United States 12 250 0.8× 160 0.5× 100 0.6× 35 0.2× 100 1.0× 27 566
Kate Sandstrom United States 9 221 0.7× 93 0.3× 99 0.6× 256 1.7× 40 0.4× 13 435
Robert Alter United States 10 264 0.9× 206 0.7× 132 0.8× 91 0.6× 60 0.6× 29 466
Zhiming Dong China 14 294 1.0× 131 0.4× 244 1.6× 101 0.7× 158 1.5× 32 688
Isabel Marugán Spain 15 273 0.9× 84 0.3× 177 1.1× 78 0.5× 33 0.3× 29 620
Katharina Balschun Germany 8 260 0.9× 107 0.4× 175 1.1× 154 1.0× 70 0.7× 8 619
Andy Su United States 5 248 0.8× 174 0.6× 199 1.3× 216 1.4× 33 0.3× 8 595

Countries citing papers authored by William Pierce

Since Specialization
Citations

This map shows the geographic impact of William Pierce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Pierce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Pierce more than expected).

Fields of papers citing papers by William Pierce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Pierce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Pierce. The network helps show where William Pierce may publish in the future.

Co-authorship network of co-authors of William Pierce

This figure shows the co-authorship network connecting the top 25 collaborators of William Pierce. A scholar is included among the top collaborators of William Pierce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Pierce. William Pierce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Beer, Tomasz M., William Pierce, B A Lowe, & W. David Henner. (2001). Phase II study of weekly docetaxel in symptomatic androgen-independent prostate cancer. Annals of Oncology. 12(9). 1273–1279. 162 indexed citations
2.
Figlin, Robert A., William Pierce, C L Tso, et al.. (1997). Treatment of Metastatic Renal Cell Carcinoma With Nephrectomy, Interleukin-2 and Cytokine-Primed or CD8(+) Selected Tumor Infiltrating Lymphocytes from Primary Tumor. The Journal of Urology. 740–745. 6 indexed citations
3.
Steger, Günther, Michael Gnant, Robert M. Mader, et al.. (1997). The in vitro effects of interleukin-12 upon tumor-infiltrating lymphocytes derived from renal cell carcinoma. Journal of Cancer Research and Clinical Oncology. 123(6). 317–324. 5 indexed citations
4.
Figlin, Robert A., William Pierce, C L Tso, et al.. (1997). Treatment of Metastatic Renal Cell Carcinoma With Nephrectomy, Interleukin-2 and Cytokine-Primed or CD8(+) Selected Tumor Infiltrating Lymphocytes from Primary Tumor. The Journal of Urology. 158(3). 740–745. 126 indexed citations
5.
Belldegrun, Arie S., Cho-Lea Tso, Randhir Kaboo, et al.. (1996). Natural Immune Reactivity-Associated Therapeutic Response in Patients with Metastatic Renal Cell Carcinoma Receiving Tumor-Infiltrating Lymphocytes and Interleukin-2-Based Therapy. Journal of Immunotherapy. 19(2). 149–161. 21 indexed citations
6.
Taneja, Samir S., et al.. (1995). Immunotherapy for renal cell carcinoma: The era of interleukin-2-based treatment. Urology. 45(6). 911–924. 31 indexed citations
7.
Pierce, William, Arie S. Belldegrun, & Robert A. Figlin. (1995). Cellular therapy: scientific rationale and clinical results in the treatment of metastatic renal-cell carcinoma.. PubMed. 22(1). 74–80. 27 indexed citations
8.
Steger, Günther, William Pierce, Robert A. Figlin, et al.. (1994). Patterns of Cytokine Release of Unselected and CD8+ Selected Renal Cell Carcinoma Tumor-Infiltrating Lymphocytes (TIL). Clinical Immunology and Immunopathology. 72(2). 237–247. 14 indexed citations
9.
Taneja, Samir S., William Pierce, Robert A. Figlin, & Arie S. Belldegrun. (1994). MANAGEMENT OF DISSEMINATED KIDNEY CANCER. Urologic Clinics of North America. 21(4). 625–637. 12 indexed citations
10.
Belldegrun, Arie S., William Pierce, D. Sayah, et al.. (1993). Soluble Tumor Necrosis Factor Receptor Expression in Patients with Metastatic Renal Cell Carcinoma Treated with Interleukin-2-Based lmmunotherapy. Journal of Immunotherapy. 13(3). 175–180. 11 indexed citations
11.
Janik, John E., William H. Sharfman, Dan L. Longo, et al.. (1993). Erythropoietin production. A potential marker for interleukin-2/interferon-responsive tumors. Cancer. 72(9). 2656–2659. 25 indexed citations
12.
Pierce, William & Robert A. Figlin. (1993). Primary tumors of the lung other than lung cancer. Current Opinion in Oncology. 5(2). 343–352. 1 indexed citations
13.
Belldegrun, Arie S., William Pierce, Randhir Kaboo, et al.. (1993). Interferon-αPrimed Tumor-Infiltrating Lymphocytes Combined with Interleukin-2 and Interferon-αas Therapy for Metastatic Renal Cell Carcinoma. The Journal of Urology. 150(5 Part 1). 1384–1390. 51 indexed citations
14.
Figlin, Robert A., et al.. (1993). Combination biologic therapy with interleukin-2 and interferon-alfa in the outpatient treatment of metastatic renal cell carcinoma.. PubMed. 20(6 Suppl 9). 11–5. 15 indexed citations
15.
16.
17.
Eggerding, Faye A. & William Pierce. (1983). Construction of a cloned library of adenovirus DNA fragments in bacteriophage M13.. Journal of Biological Chemistry. 258(16). 10090–10097. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Luz Tovar García Breakdown of academic impact, for papers by M.R. Sertoli Breakdown of academic impact, for papers by Carla M. van Herpen Breakdown of academic impact, for papers by Edmonson Jh Breakdown of academic impact, for papers by Kate Sandstrom Breakdown of academic impact, for papers by Robert Alter Breakdown of academic impact, for papers by Zhiming Dong Breakdown of academic impact, for papers by Isabel Marugán Breakdown of academic impact, for papers by Katharina Balschun Breakdown of academic impact, for papers by Andy Su
Rankless by CCL
2026